Aytu Biopharma (AYTU) Profit After Tax (2010 - 2026)
Aytu Biopharma (AYTU) reported Profit After Tax of -$5.6 million for Q1 2026, down 242.59% year-over-year from $3.9 million in Q1 2025, and up 46.92% quarter-over-quarter from -$10.6 million in Q4 2025.
Aytu Biopharma (AYTU) Profit After Tax (2010 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has 17 years of Profit After Tax data on file, last reported at -$5.6 million in Q1 2026.
- Profit After Tax for Q1 2026 came in at -$5.6 million, down 242.59% year-over-year; the trailing twelve-month figure through Mar 2026 was -$34.7 million (down 806.36% YoY), and the FY2025 annual result was -$14.2 million, down 13.27% from the prior year.
- Profit After Tax rose to -$5.6 million in Q1 2026 per AYTU's latest filing, from -$10.6 million in the prior quarter.
- Over five years, Profit After Tax peaked at $3.9 million in Q1 2025 and troughed at -$53.3 million in Q1 2022.
- A 5-year average of -$7.5 million and a median of -$2.9 million in 2024 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2024 and 2025: Profit After Tax surged 458.18% in 2024, then slumped 1480.67% in 2025.
- A 5-year view of Profit After Tax shows it stood at -$6.7 million in 2022, then jumped by 96.71% to -$220000.0 in 2023, then surged by 458.18% to $788000.0 in 2024, then tumbled by 1443.15% to -$10.6 million in 2025, then soared by 46.92% to -$5.6 million in 2026.
- Business Quant data shows AYTU's Profit After Tax at -$5.6 million in Q1 2026, -$10.6 million in Q4 2025, and $2.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 369.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -1.36 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 16.20 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 118.42 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -92.12 Mn |
| 10 | Aytu Biopharma | 24.18 Mn | -2.54 Mn | 7.60 Mn | -5.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.62 Mn |
| Dec 31, 2025 | -10.58 Mn |
| Sep 30, 2025 | 1.97 Mn |
| Jun 30, 2025 | -20.44 Mn |
| Mar 31, 2025 | 3.94 Mn |
| Dec 31, 2024 | 788,000.00 |
| Sep 30, 2024 | 1.47 Mn |
| Jun 30, 2024 | -1.29 Mn |
| Mar 31, 2024 | -2.89 Mn |
| Dec 31, 2023 | -220,000.00 |
| Sep 30, 2023 | -8.12 Mn |
| Jun 30, 2023 | -2.46 Mn |
| Mar 31, 2023 | -7.20 Mn |
| Dec 31, 2022 | -6.69 Mn |
| Sep 30, 2022 | -701,000.00 |
| Jun 30, 2022 | -16.09 Mn |
| Mar 31, 2022 | -53.29 Mn |
| Dec 31, 2021 | -11.55 Mn |
| Sep 30, 2021 | -27.85 Mn |
| Jun 30, 2021 | -19.00 Mn |